Guided Therapeutics (GTHP) Preferred Dividend Payments (2013 - 2025)

Guided Therapeutics has disclosed Preferred Dividend Payments across 13 years of filings, most recently posting $24000.0 for Q4 2025.

• Preferred Dividend Payments for Q4 2025 came in at $24000.0, down 50.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $148000.0 (down 14.94% YoY), and the FY2025 annual result was $150000.0, down 13.79% from the prior year.
• Preferred Dividend Payments came in at $24000.0 for Q4 2025 at Guided Therapeutics, down from $43000.0 in the prior quarter.
• In the past five years, Preferred Dividend Payments ranged from a high of $548000.0 in Q1 2022 to a low of -$55000.0 in Q1 2021.
• The 5-year median for Preferred Dividend Payments is $47500.0 (2022), against an average of $73700.0.
• Across the five-year window, Preferred Dividend Payments tumbled 558.33% in 2021 and surged 1096.36% in 2022, its largest moves.
• Guided Therapeutics' Preferred Dividend Payments stood at $65000.0 in 2021, then declined by 23.08% to $50000.0 in 2022, then retreated by 2.0% to $49000.0 in 2023, then dropped by 2.04% to $48000.0 in 2024, then slumped by 50.0% to $24000.0 in 2025.
• The last three Preferred Dividend Payments figures came in at $24000.0 (Q4 2025), $43000.0 (Q3 2025), and $45000.0 (Q2 2025), per Business Quant data.